Search results
Shah Capital ends campaign against Novavax board after Sanofi deal By Reuters
Investing.com· 1 day agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now | The Motley Fool
The Motley Fool· 5 days agoIf you'd invested $10,000 in Novavax (NVAX 9.26%) a year ago, you would have made a risky bet. Prior...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 2 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
Could Novavax Become the Next Moderna?
The Motley Fool via AOL· 4 days agoNovavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their...
Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 3 days agoNovavax (NASDAQ: NVAX) has been a highly volatile stock in recent years, and that volatility is on full display again this month. Shares of the...
Could Novavax Become the Next Moderna? | The Motley Fool
The Motley Fool· 4 days agoNovavax (NVAX -9.65%) and Moderna (MRNA 0.17%) both entered the coronavirus vaccine race around the...
1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?
Motley Fool via Yahoo Finance· 6 days agoNovavax (NASDAQ: NVAX) took a turn in the investor spotlight in early May, when the vaccine...
Novavax Stock Just Tripled. Is It Too Late to Buy? | The Motley Fool
The Motley Fool· 6 days agoAfter losing more than 90% of its value from a peak back in 2021, Novavax (NVAX -4.30%) stock has...
Shah Capital ends campaign against Novavax board after Sanofi deal
WSAU Wausau· 1 day ago(Reuters) - Hedge fund Shah Capital said on Monday it would withdraw its campaign against the...
Novavax Stock Just Tripled. Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 6 days agoAfter losing more than 90% of its value from a peak back in 2021, Novavax (NASDAQ: NVAX) stock has finally taken off. The biotech soared 190% in two...